WO2004085460A1 - Process for preparing crystalline ciclesonide with defined particle size - Google Patents
Process for preparing crystalline ciclesonide with defined particle size Download PDFInfo
- Publication number
- WO2004085460A1 WO2004085460A1 PCT/EP2004/050373 EP2004050373W WO2004085460A1 WO 2004085460 A1 WO2004085460 A1 WO 2004085460A1 EP 2004050373 W EP2004050373 W EP 2004050373W WO 2004085460 A1 WO2004085460 A1 WO 2004085460A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- water
- process according
- particle size
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F21/00—Dissolving
Abstract
Description
Claims
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006505496A JP4746535B2 (en) | 2003-03-27 | 2004-03-26 | Method for producing crystalline ciclesonide having a defined particle size |
SI200431866T SI1611150T1 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
NZ542827A NZ542827A (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
AU2004224092A AU2004224092B2 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
DK04723609.6T DK1611150T3 (en) | 2003-03-27 | 2004-03-26 | Process for the preparation of crystalline ciclesonide with defined particle size |
AT04723609T ATE546459T1 (en) | 2003-03-27 | 2004-03-26 | METHOD FOR PRODUCING CRYSTALLINE CICLESONIDE WITH A DEFINED PARTICLE SIZE |
MXPA05010041A MXPA05010041A (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size. |
YU20050704A RS52549B (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
PL04723609T PL1611150T3 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
CA2519752A CA2519752C (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
KR1020057017580A KR101102709B1 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
US10/549,631 US9422327B2 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
EP04723609A EP1611150B1 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
ES04723609T ES2382928T3 (en) | 2003-03-27 | 2004-03-26 | Procedure for preparing crystalline ciclesonide with defined particle size |
EA200501391A EA011157B1 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
BRPI0408569-8A BRPI0408569B1 (en) | 2003-03-27 | 2004-03-26 | METHOD FOR PREPARING FORMULA I COMPOUND IN THE CRYSTALLINE FORM |
IL170746A IL170746A (en) | 2003-03-27 | 2005-09-08 | Process for preparing crystalline ciclesonide |
HRP20050917AA HRP20050917B1 (en) | 2003-03-27 | 2005-10-19 | Process for preparing crystalline ciclesonide with defined particle size |
NO20054835A NO331984B1 (en) | 2003-03-27 | 2005-10-19 | Crystalline ciclesonide of defined particle size, process for preparing the same and pharmaceutical composition comprising the same |
HK06109236.9A HK1088905A1 (en) | 2003-03-27 | 2006-08-21 | Process for preparing crystalline ciclesonide with defined particle size |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007007.2 | 2003-03-27 | ||
EP03007007 | 2003-03-27 | ||
DE10314097.2 | 2003-03-27 | ||
DE10314097 | 2003-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004085460A1 true WO2004085460A1 (en) | 2004-10-07 |
WO2004085460A8 WO2004085460A8 (en) | 2007-03-15 |
Family
ID=33099298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/050373 WO2004085460A1 (en) | 2003-03-27 | 2004-03-26 | Process for preparing crystalline ciclesonide with defined particle size |
Country Status (28)
Country | Link |
---|---|
US (1) | US9422327B2 (en) |
EP (1) | EP1611150B1 (en) |
JP (1) | JP4746535B2 (en) |
KR (1) | KR101102709B1 (en) |
AR (1) | AR043579A1 (en) |
AT (1) | ATE546459T1 (en) |
AU (1) | AU2004224092B2 (en) |
BR (1) | BRPI0408569B1 (en) |
CA (1) | CA2519752C (en) |
CL (1) | CL2004000636A1 (en) |
CY (1) | CY1112970T1 (en) |
DK (1) | DK1611150T3 (en) |
EA (1) | EA011157B1 (en) |
ES (1) | ES2382928T3 (en) |
HK (1) | HK1088905A1 (en) |
HR (1) | HRP20050917B1 (en) |
IL (1) | IL170746A (en) |
MX (1) | MXPA05010041A (en) |
MY (1) | MY143936A (en) |
NO (1) | NO331984B1 (en) |
NZ (1) | NZ542827A (en) |
PE (1) | PE20050388A1 (en) |
PL (1) | PL1611150T3 (en) |
PT (1) | PT1611150E (en) |
RS (1) | RS52549B (en) |
SI (1) | SI1611150T1 (en) |
TW (1) | TWI328589B (en) |
WO (1) | WO2004085460A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007056181A2 (en) * | 2005-11-02 | 2007-05-18 | Sicor, Inc. | Process for the preparation of ciclesonide |
WO2007092574A2 (en) * | 2006-02-08 | 2007-08-16 | Sicor, Inc. | Crystalline forms of ciclesonide |
WO2008015696A2 (en) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Process for preparing ciclesonide |
WO2008062450A2 (en) * | 2006-09-18 | 2008-05-29 | Cadila Healthcare Limited | Crystalline polymorphs of ciclesonide |
WO2008035066A3 (en) * | 2006-09-19 | 2009-02-26 | Cipla Ltd | Processes for the preparation of ciclesonide and its crystal form |
WO2010054158A2 (en) * | 2008-11-07 | 2010-05-14 | Auspex Pharmaceuticals, Inc. | Steroid modulators of glucocorticoid receptor |
ITMI20090016A1 (en) * | 2009-01-09 | 2010-07-10 | Farmabios Spa | PROCESS FOR THE PREPARATION OF CICLESONIDE |
WO2013124395A1 (en) | 2012-02-23 | 2013-08-29 | Boehringer Ingelheim International Gmbh | Novel method for manufacturing of ciclesonide |
US10111957B2 (en) | 2012-07-05 | 2018-10-30 | Arven Ilac Snayi ve Ticaret A.S. | Inhalation compositions comprising glucose anhydrous |
US11052042B2 (en) | 2003-12-16 | 2021-07-06 | Covis Pharma Gmbh | Aqueous suspensions of ciclesonide for nebulisation |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009112557A2 (en) * | 2008-03-13 | 2009-09-17 | Farmabios S.P.A. | Process for the preparation of pregnane derivatives |
WO2014007770A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising corticosteroid and sorbitol |
WO2014007781A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions |
CR20180594A (en) | 2016-06-02 | 2019-07-29 | Abbvie Inc | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF |
RU2020117698A (en) | 2017-12-01 | 2022-01-04 | Эббви Инк. | GLUCOCORTICOID RECEPTOR AGONIST AND ITS IMMUNOCONJUGATES |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605517A (en) * | 1983-10-29 | 1986-08-12 | Sterling Drug Inc. | Method of preparing steroid compounds of controlled particle size |
WO1998009982A1 (en) | 1996-09-03 | 1998-03-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives |
WO2001000046A1 (en) * | 1999-06-25 | 2001-01-04 | Cognis Deutschland Gmbh | Use of nanoscale sterols and sterol esters |
WO2002038584A1 (en) | 2000-11-10 | 2002-05-16 | Altana Pharma Ag | Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
US6482438B1 (en) * | 1998-12-24 | 2002-11-19 | Smithkline Beecham Corporation | Apparatus and process for preparing crystalline particles |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2843857B2 (en) | 1988-10-05 | 1999-01-06 | ファルマシア・アンド・アップジョン・カンパニー | Finely divided solid crystalline powder via precipitation in antisolvent |
EP0407028B2 (en) | 1989-05-31 | 1999-07-07 | FISONS plc | Medicament inhalation device and formulation |
GR1001529B (en) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Process for the obtainment of a new pregna-1,4-diene-3,20-dione -16-17-acetal-21 esters |
FR2668945B1 (en) | 1990-11-12 | 1993-02-19 | Theramex | NEW PROCESS FOR THE CRYSTALLIZATION OF ORGANIC SUBSTANCES AND THE COMPOUNDS THUS OBTAINED. |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
GB9213874D0 (en) | 1992-06-30 | 1992-08-12 | Fisons Plc | Process to novel medicament form |
GB9306703D0 (en) | 1993-03-31 | 1993-05-26 | Fisons Plc | Inhalation device |
HU220868B1 (en) * | 1993-04-02 | 2002-06-29 | Byk Gulden Lomberg Chem Fab | New prednisolone derivative, process for its production, use of the same and pharmaceutical composition containing the same |
IL111194A (en) | 1993-10-08 | 1998-02-08 | Fisons Plc | Process for the production of medicament formulations |
ES2154725T3 (en) * | 1994-03-09 | 2001-04-16 | Byk Gulden Lomberg Chem Fab | NEW SILILO COMPOUNDS AND ITS USE. |
DE19541689A1 (en) | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Medicament contg. ciclesonid and beta2-sympathomimetic |
US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
GB9722285D0 (en) | 1997-10-23 | 1997-12-17 | Rhone Poulenc Rorer Ltd | Inhalation device |
US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
ES2234266T3 (en) * | 1998-07-24 | 2005-06-16 | Jago Research Ag | MEDICAL FORMULATIONS FOR AEROSOLS. |
AR026073A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE |
AR026072A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION |
-
2004
- 2004-02-13 MY MYPI20040475A patent/MY143936A/en unknown
- 2004-02-19 TW TW093104136A patent/TWI328589B/en not_active IP Right Cessation
- 2004-03-12 AR ARP040100815A patent/AR043579A1/en unknown
- 2004-03-25 CL CL200400636A patent/CL2004000636A1/en unknown
- 2004-03-25 PE PE2004000317A patent/PE20050388A1/en not_active Application Discontinuation
- 2004-03-26 DK DK04723609.6T patent/DK1611150T3/en active
- 2004-03-26 PL PL04723609T patent/PL1611150T3/en unknown
- 2004-03-26 JP JP2006505496A patent/JP4746535B2/en not_active Expired - Lifetime
- 2004-03-26 SI SI200431866T patent/SI1611150T1/en unknown
- 2004-03-26 NZ NZ542827A patent/NZ542827A/en unknown
- 2004-03-26 ES ES04723609T patent/ES2382928T3/en not_active Expired - Lifetime
- 2004-03-26 BR BRPI0408569-8A patent/BRPI0408569B1/en active IP Right Grant
- 2004-03-26 MX MXPA05010041A patent/MXPA05010041A/en active IP Right Grant
- 2004-03-26 EP EP04723609A patent/EP1611150B1/en not_active Expired - Lifetime
- 2004-03-26 CA CA2519752A patent/CA2519752C/en not_active Expired - Fee Related
- 2004-03-26 EA EA200501391A patent/EA011157B1/en not_active IP Right Cessation
- 2004-03-26 US US10/549,631 patent/US9422327B2/en active Active
- 2004-03-26 AT AT04723609T patent/ATE546459T1/en active
- 2004-03-26 KR KR1020057017580A patent/KR101102709B1/en active IP Right Grant
- 2004-03-26 RS YU20050704A patent/RS52549B/en unknown
- 2004-03-26 WO PCT/EP2004/050373 patent/WO2004085460A1/en active Application Filing
- 2004-03-26 AU AU2004224092A patent/AU2004224092B2/en not_active Expired
- 2004-03-26 PT PT04723609T patent/PT1611150E/en unknown
-
2005
- 2005-09-08 IL IL170746A patent/IL170746A/en active IP Right Grant
- 2005-10-19 HR HRP20050917AA patent/HRP20050917B1/en not_active IP Right Cessation
- 2005-10-19 NO NO20054835A patent/NO331984B1/en unknown
-
2006
- 2006-08-21 HK HK06109236.9A patent/HK1088905A1/en not_active IP Right Cessation
-
2012
- 2012-05-08 CY CY20121100425T patent/CY1112970T1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605517A (en) * | 1983-10-29 | 1986-08-12 | Sterling Drug Inc. | Method of preparing steroid compounds of controlled particle size |
WO1998009982A1 (en) | 1996-09-03 | 1998-03-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives |
DE19635498A1 (en) * | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Process for epimer enrichment |
US6482438B1 (en) * | 1998-12-24 | 2002-11-19 | Smithkline Beecham Corporation | Apparatus and process for preparing crystalline particles |
WO2001000046A1 (en) * | 1999-06-25 | 2001-01-04 | Cognis Deutschland Gmbh | Use of nanoscale sterols and sterol esters |
WO2002038584A1 (en) | 2000-11-10 | 2002-05-16 | Altana Pharma Ag | Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11052042B2 (en) | 2003-12-16 | 2021-07-06 | Covis Pharma Gmbh | Aqueous suspensions of ciclesonide for nebulisation |
WO2007056181A3 (en) * | 2005-11-02 | 2007-08-02 | Sicor Inc | Process for the preparation of ciclesonide |
WO2007056181A2 (en) * | 2005-11-02 | 2007-05-18 | Sicor, Inc. | Process for the preparation of ciclesonide |
WO2007092574A2 (en) * | 2006-02-08 | 2007-08-16 | Sicor, Inc. | Crystalline forms of ciclesonide |
WO2007092574A3 (en) * | 2006-02-08 | 2007-10-18 | Sicor Inc | Crystalline forms of ciclesonide |
JP2009526068A (en) * | 2006-02-08 | 2009-07-16 | シコール インコーポレイティド | Ciclesonide crystal form |
WO2008015696A2 (en) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Process for preparing ciclesonide |
WO2008015696A3 (en) * | 2006-05-23 | 2008-05-29 | Cadila Healthcare Ltd | Process for preparing ciclesonide |
WO2008062450A2 (en) * | 2006-09-18 | 2008-05-29 | Cadila Healthcare Limited | Crystalline polymorphs of ciclesonide |
WO2008062450A3 (en) * | 2006-09-18 | 2008-11-20 | Cadila Healthcare Ltd | Crystalline polymorphs of ciclesonide |
WO2008035066A3 (en) * | 2006-09-19 | 2009-02-26 | Cipla Ltd | Processes for the preparation of ciclesonide and its crystal form |
US8158780B2 (en) | 2006-09-19 | 2012-04-17 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal modification |
WO2010054158A3 (en) * | 2008-11-07 | 2010-08-19 | Auspex Pharmaceuticals, Inc. | Steroid modulators of glucocorticoid receptor |
WO2010054158A2 (en) * | 2008-11-07 | 2010-05-14 | Auspex Pharmaceuticals, Inc. | Steroid modulators of glucocorticoid receptor |
ITMI20090016A1 (en) * | 2009-01-09 | 2010-07-10 | Farmabios Spa | PROCESS FOR THE PREPARATION OF CICLESONIDE |
WO2013124395A1 (en) | 2012-02-23 | 2013-08-29 | Boehringer Ingelheim International Gmbh | Novel method for manufacturing of ciclesonide |
US10111957B2 (en) | 2012-07-05 | 2018-10-30 | Arven Ilac Snayi ve Ticaret A.S. | Inhalation compositions comprising glucose anhydrous |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL170746A (en) | Process for preparing crystalline ciclesonide | |
EP0937100A1 (en) | A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof | |
EP1572153B1 (en) | Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation | |
JP2006502172A (en) | Anti-inflammatory or anti-allergic androstane complex | |
EP1893220A1 (en) | Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction | |
SI9210065A (en) | Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation | |
HUE034315T2 (en) | Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl ester and its use for the treatment of pulmonary di... | |
EP1472272B1 (en) | Crystalline complexes of fluticasone 2-furoate | |
US20030109511A1 (en) | Novel anti-inflammatory androstane derivative compositions | |
KR20140048237A (en) | Process for the preparation of fluticasone propionate form 1 | |
ZA200506943B (en) | Process for preparing cryalline ciclesonide with defined particle size | |
US20100120737A1 (en) | Amorphous ciclesonide | |
WO2008062450A2 (en) | Crystalline polymorphs of ciclesonide | |
US10993879B2 (en) | Pulmonary delivery of progestogen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-2005/0704 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004723609 Country of ref document: EP Ref document number: 2005/06943 Country of ref document: ZA Ref document number: 200506943 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 170746 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006505496 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057017580 Country of ref document: KR Ref document number: 20048074813 Country of ref document: CN Ref document number: 2519752 Country of ref document: CA Ref document number: PA/a/2005/010041 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200501391 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 542827 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20050917A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004224092 Country of ref document: AU Ref document number: 1158/MUMNP/2005 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2006128954 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10549631 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2004224092 Country of ref document: AU Date of ref document: 20040326 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004224092 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057017580 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004723609 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0408569 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 10549631 Country of ref document: US |